ENTA
Price
$11.58
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
27 days until earnings call
GBIO
Price
$2.34
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
9 days until earnings call
Ad is loading...

ENTA vs GBIO

Header iconENTA vs GBIO Comparison
Open Charts ENTA vs GBIOBanner chart's image
Enanta Pharmaceuticals
Price$11.58
Change-$0.00 (-0.00%)
Volume$93.75K
CapitalizationN/A
Generation Bio
Price$2.34
Change-$0.00 (-0.00%)
Volume$70.15K
CapitalizationN/A
View a ticker or compare two or three
ENTA vs GBIO Comparison Chart
Loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ENTA vs. GBIO commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a StrongBuy and GBIO is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (ENTA: $11.58 vs. GBIO: $2.34)
Brand notoriety: ENTA and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 59% vs. GBIO: 66%
Market capitalization -- ENTA: $212.95M vs. GBIO: $162.18M
ENTA [@Biotechnology] is valued at $212.95M. GBIO’s [@Biotechnology] market capitalization is $162.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTA is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 5 TA indicator(s) are bullish while GBIO’s TA Score has 2 bullish TA indicator(s).

  • ENTA’s TA Score: 5 bullish, 6 bearish.
  • GBIO’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ENTA is a better buy in the short-term than GBIO.

Price Growth

ENTA (@Biotechnology) experienced а -8.39% price change this week, while GBIO (@Biotechnology) price change was +4.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ENTA is expected to report earnings on Feb 05, 2025.

GBIO is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTA($213M) has a higher market cap than GBIO($162M). GBIO YTD gains are higher at: 41.818 vs. ENTA (23.061). ENTA (-104.08M) and GBIO (-107.1M) have comparable annual earnings (EBITDA) . ENTA has more cash in the bank: 230M vs. GBIO (217M). ENTA has less debt than GBIO: ENTA (50.6M) vs GBIO (94M). ENTA has higher revenues than GBIO: ENTA (72M) vs GBIO (13.2M).
ENTAGBIOENTA / GBIO
Capitalization213M162M131%
EBITDA-104.08M-107.1M97%
Gain YTD23.06141.81855%
P/E RatioN/AN/A-
Revenue72M13.2M545%
Total Cash230M217M106%
Total Debt50.6M94M54%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
1

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTAGBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
70%
Bullish Trend 16 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with ETNB. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
-0.86%
ETNB - ENTA
44%
Loosely correlated
+1.91%
INZY - ENTA
43%
Loosely correlated
-0.21%
ARWR - ENTA
42%
Loosely correlated
+0.40%
GBIO - ENTA
40%
Loosely correlated
+9.35%
DYN - ENTA
40%
Loosely correlated
+0.39%
More

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with EDIT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+9.35%
EDIT - GBIO
48%
Loosely correlated
+2.52%
TECH - GBIO
47%
Loosely correlated
+2.48%
INZY - GBIO
47%
Loosely correlated
-0.21%
NTLA - GBIO
47%
Loosely correlated
+2.45%
BEAM - GBIO
46%
Loosely correlated
+3.71%
More